ArticlePharmaceutics2025

Sitagliptin Potentiates the Anticancer Activity of Doxorubicin Through ROS-Driven Apoptosis and MMP/TIMP Regulation in HeLa Cells.

Aşkın Evren Güler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.